These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 24807718)

  • 1. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
    Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
    J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cre/loxP-Based Recombinant HBV cccDNA System In Vitro and In Vivo.
    Zheng Y; Deng Q
    Methods Mol Biol; 2024; 2837():185-198. PubMed ID: 39044085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.
    Li G; Zhu Y; Shao D; Chang H; Zhang X; Zhou D; Gao Y; Lan K; Deng Q
    Hepatology; 2018 Jan; 67(1):56-70. PubMed ID: 28749559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.
    Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z
    Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.
    Kruse RL; Legras X; Barzi M
    Virus Res; 2021 Jan; 292():198224. PubMed ID: 33166564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus.
    Zhou Z; Li C; Tan Z; Sun G; Peng B; Ren T; He J; Wang Y; Sun Y; Wang F; Li W
    Antiviral Res; 2023 Aug; 216():105642. PubMed ID: 37253400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
    Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
    Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System.
    Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z
    mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of cccDNA in HBV Maintenance.
    Allweiss L; Dandri M
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
    Guo X; Chen P; Hou X; Xu W; Wang D; Wang TY; Zhang L; Zheng G; Gao ZL; He CY; Zhou B; Chen ZY
    Sci Rep; 2016 May; 6():25552. PubMed ID: 27174254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome.
    Kruse RL; Barzi M; Legras X; Pankowicz FP; Furey N; Liao L; Xu J; Bissig-Choisat B; Slagle BL; Bissig KD
    JHEP Rep; 2021 Apr; 3(2):100252. PubMed ID: 33733079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
    Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S
    Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the study of hepatitis B virus covalently closed circular DNA.
    Ji M; Hu K
    Virol Sin; 2017 Dec; 32(6):454-464. PubMed ID: 29280054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
    Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.